DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Bollag G, Tsai J, Zhang J et al.
Vemurafenib: the first drug approved for BRAF-mutant cancer.
Nat Rev Drug Discov 2012;
11: 873-886
We do not assume any responsibility for the contents of the web pages of other providers.